Stoke Therapeutics Ownership | Who Owns Stoke Therapeutics?

Overview Forecast RevenueFinancials Chart

Stoke Therapeutics Ownership Summary

Stoke Therapeutics is owned by 116.35% institutional investors, 3.82% insiders. Blackrock is the largest institutional shareholder, holding 11.70% of STOK shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 3.03% of its assets in Stoke Therapeutics shares.

STOK Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Stoke Therapeutics	116.35%	3.82%	-20.17%
Sector	Healthcare Stocks	35.70%	12.04%	52.26%
Industry	Biotech Stocks	35.48%	11.92%	52.60%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Blackrock	5.41M	11.70%	$73.08M
Rtw investments, lp	5.62M	9.50%	$183.10M
Blackrock funding, inc. /de	5.39M	9.09%	$175.36M
Fmr	5.38M	9.09%	$175.29M
Lynx1 capital management lp	4.76M	8.04%	$155.11M
Cowen and company	3.37M	7.28%	$45.47M
Redmile group	4.16M	7.03%	$135.58M
Morgan stanley	3.42M	5.78%	$111.46M
Baker bros. advisors lp	3.34M	5.63%	$108.64M
Vanguard group	3.15M	5.37%	$99.96M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Skorpios trust	2.26M	99.68%	$53.02M
Lynx1 capital management lp	4.76M	24.51%	$155.11M
Redmile group	4.16M	8.98%	$135.58M
Birchview capital, lp	210.00K	3.89%	$6.84M
Opaleye management	700.00K	3.00%	$22.79M
Bvf inc/il	2.55M	2.64%	$82.95M
Bioimpact capital	767.04K	1.93%	$24.97M
Rtw investments, lp	5.62M	1.82%	$183.10M
Siren	2.00M	1.80%	$64.97M
Checkpoint capital	212.05K	1.67%	$4.98M

Top Buyers

Holder	Shares	% Assets	Change
Wellington management group llp	3.10M	0.02%	2.36M
Price t rowe associates inc /md/	1.93M	0.01%	1.56M
Blackrock	5.41M	0.00%	1.55M
Troluce capital advisors	652.80K	1.30%	652.80K
Millennium management	472.14K	0.01%	472.14K

Top Sellers

Holder	Shares	% Assets	Change
Janus henderson group	18.90K	0.00%	-1.43M
Healthcare of ontario pension plan trust fund	-	-	-1.39M
Point72 asset management	-	-	-1.22M
Logos global management lp	-	-	-1.05M
Skorpios trust	2.26M	99.68%	-1.00M

New Positions

Holder	Shares	% Assets	Change	Value
Troluce capital advisors	652.80K	1.30%	652.80K	$21.26M
Vanguard fiduciary trust	356.95K	0.00%	356.95K	$11.62M
Artisan partners limited partnership	315.49K	0.02%	315.49K	$10.27M
Norges bank	314.80K	0.00%	314.80K	$3.47M
T. rowe price investment management	250.91K	0.01%	250.91K	$8.17M

Sold Out

Holder	Change
Nelson, van denburg & campbell wealth management group	-5.00
Mid-american wealth advisory group	-17.00
Srs capital advisors	-21.00
Lindbrook capital	-30.00
Capital performance advisors llp	-32.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Mar 31, 2026	200	3.63%	68,902,374	2.86%	116	0.89%	116	13.73%	54	-8.47%
Dec 31, 2025	82	-47.44%	14,262,199	-78.93%	24	0.18%	43	-52.22%	21	-46.15%
Sep 30, 2025	64	-49.61%	15,482,785	-74.37%	26	0.25%	38	-47.95%	16	-44.83%
Jun 30, 2025	133	4.72%	65,529,807	16.03%	112	1.18%	73	2.82%	33	22.22%
Mar 31, 2025	128	-2.29%	63,381,918	9.17%	109	1.03%	70	4.48%	28	-33.33%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	1.89M	3.03%	152.84K
Vanguard US Total Market Shares ETF	1.61M	2.97%	-
Vanguard Health Care Inv	1.65M	2.65%	1.65M
State Street® SPDR® S&P® Biotech ETF	1.57M	2.52%	-34.92K
iShares Russell 2000 ETF	1.42M	2.28%	8.45K
Fidelity Select Biotechnology	1.29M	2.08%	73.30K
BGF World Healthscience A2 USD	851.11K	1.56%	-
Polar Capital Biotech S Inc	789.60K	1.27%	-281.59K
T. Rowe Price New Horizons	729.20K	1.17%	187.90K
SPDR® S&P Biotech ETF	626.96K	1.14%	1.40K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Jul 01, 2026	Ticho Barry	CHIEF MEDICAL OFFICER	Sell	$219.43K
Jul 01, 2026	Ticho Barry	CHIEF MEDICAL OFFICER	Sell	$16.63K
Jun 16, 2026	Allan Jonathan	GENERAL COUNSEL & CORP SEC	Sell	$43.64K
Jun 01, 2026	Ticho Barry	CHIEF MEDICAL OFFICER	Sell	$54.89K
May 01, 2026	Ticho Barry	CHIEF MEDICAL OFFICER	Sell	$73.55K

Insider Transactions Trends

Date	Buy	Sell
2026 Q3	-	2
2026 Q2	-	4
2026 Q1	-	27
2025 Q4	-	42
2025 Q3	-	13

STOK Ownership FAQ

Who Owns Stoke Therapeutics?

Stoke Therapeutics shareholders are primarily institutional investors at 116.35%, followed by 3.82% insiders and -20.17% retail investors. The average institutional ownership in Stoke Therapeutics's industry, Biotech Stocks , is 35.48%, which Stoke Therapeutics exceeds.

Who owns the most shares of Stoke Therapeutics?

Stoke Therapeutics’s largest shareholders are Blackrock (5.41M shares, 11.70%), Rtw investments, lp (5.62M shares, 9.50%), and Blackrock funding, inc. /de (5.39M shares, 9.09%). Together, they hold 30.29% of Stoke Therapeutics’s total shares outstanding.

Does Blackrock own Stoke Therapeutics?

Yes, BlackRock owns 11.70% of Stoke Therapeutics, totaling 5.41M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 73.08M$. In the last quarter, BlackRock increased its holdings by 1.55M shares, a 40.19% change.

Who is Stoke Therapeutics’s biggest shareholder by percentage of total assets invested?

Skorpios trust is Stoke Therapeutics’s biggest shareholder by percentage of total assets invested, with 99.68% of its assets in 2.26M Stoke Therapeutics shares, valued at 53.02M$.

Who is the top mutual fund holder of Stoke Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Stoke Therapeutics shares, with 3.03% of its total shares outstanding invested in 1.89M Stoke Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools